Orthopedic Product Guide » Vimovo tablets http://blog.orthopedicproductguide.com A comprehensive guide to orthopedic products for medical professionals Wed, 29 Sep 2010 14:31:20 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 AstraZeneca and Pozen file European MAA for arthritis drug http://blog.orthopedicproductguide.com/2009/12/24/astrazeneca-and-pozen-file-european-maa-for-arthritis-drug/ http://blog.orthopedicproductguide.com/2009/12/24/astrazeneca-and-pozen-file-european-maa-for-arthritis-drug/#comments Thu, 24 Dec 2009 05:50:54 +0000 Josie Rich http://www.orthopedicproductguide.com/blog/?p=181 AstraZenecaAstraZeneca and Pozen have submitted a marketing authorization application or MAA in the EU via the decentralized procedure for Vimovo tablets, a product under investigation for the treatment of the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk of developing non-steroidal anti-inflammatory drug-associated ulcers. Vimovo is a fixed-dose combination of enteric coated naproxen and immediate release esomeprazole under co-development by AstraZeneca and Pozen.

For  the full story, Click Here

]]> http://blog.orthopedicproductguide.com/2009/12/24/astrazeneca-and-pozen-file-european-maa-for-arthritis-drug/feed/ 0